JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CUETO, C.
Right arrow Articles by MORAN, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CUETO, C., JR.
Right arrow Articles by MORAN, N. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 164, Issue 1, 31-44, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


THE CIRCULATORY EFFECTS OF CATECHOLAMINES AND OUABAIN IN GLUCOCORTICOID-DEFICIENT ANIMALS

CIPRIANO CUETO JR. 1 and NEIL C. MORAN 1

1 Department of Pharmacology, Division of Basic Health Sciences, Emory University, Atlanta, Georgia

Glucocorticoid deficiency produced in dogs by chronic administration of dichloro-diphenyl-dichloroethane (o,p'-DDD) was demonstrated by decreased plasma 17-OH-corticosteroids (17-OHCS), abolition of ACTH-induced increase of 17-OHCS and ACTH-induced decrease of eosinophils. Plasma Na+, K+ and volume and blood pressure and heart rate were unaltered. After 2 weeks of treatment with DDD the dogs were anesthetized for experimentation. Blood pressure and heart contractile force and rate responses to graded doses of epinephrine and norepinephrine were determined in one series of treated dogs and were compared to those in untreated dogs. As a final test, cardiac contractile force response to ouabain was determined in most dogs. Cardioaccelerator and vasopressor responses to the amines and cardiac contractile force responses to ouabain were similar in treated and untreated dogs. However, the positive inotropic effect of high doses of amines was depressed in treated dogs. Administration of prednisolone for 3 days reversed these effects of DDD. DDD-induced glucocorticoid deficiency produced little apparent direct circulatory effect but diminished the animals' ability to withstand stressful procedures, such as thoracotomy and multiple injections of vasopressor amines. Blood pressure and blood volume declined progressively during the course of experiments in DDD-treated dogs but not in untreated dogs. Similar hypovolemic shock was produced in anesthetized dogs by repeated i.v. injections of epinephrine and norepinephrine but not by isoproterenol, a vasodepressor amine. The mechanism of the loss of blood volume is not known. It is not due to histamine release. Prednisolone prevented the development of hypovolemic shock in DDD-treated dogs.

Submitted on March 11, 1968
Accepted on June 11, 1968




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
Y.-C. Chen, M. A. Cadnapaphornchai, S. N. Summer, S. Falk, C. Li, W. Wang, and R. W. Schrier
Molecular Mechanisms of Impaired Urinary Concentrating Ability in Glucocorticoid-Deficient Rats
J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2864 - 2871.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.